Telemetry Investments’s Esperion Therapeutics ESPR Stock Holding History

Telemetry Investments’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$442K	Buy	+71,000	New	+$508K	0.7%	35
2022 Q2	–	Sell	-17,500	Closed	-$81K	–	180
2022 Q1	$81K	Sell	17,500 -33,000	-65%	-$142K	0.13%	110
2021 Q4	$252K	Buy	+50,500	New	+$404K	0.32%	103
2019 Q2	–	Sell	-7,500	Closed	-$301K	–	94
2019 Q1	$301K	Buy	+7,500	New	+$336K	0.15%	65
2016 Q3	–	Sell	-20,500	Closed	-$203K	–	112
2016 Q2	$203K	Sell	20,500 -12,500	-38%	-$207K	0.11%	89
2016 Q1	$558K	Sell	33,000 -19,000	-37%	-$306K	0.16%	55
2015 Q4	$1.16M	Buy	+52,000	New	+$1.31M	0.39%	44

Other funds holding ESPR

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return